查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1461248

盐酸羟考酮市场评估：依纯度、类型、形式、应用和地区划分的机会和预测（2017-2031）

Oxycodone Hydrochloride Market Assessment, By Purity, By Type, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 238 Pages | 商品交期: 3-5个工作天内

价格

全球盐酸羟考酮市场规模将从 2023 年的 4.215 亿美元成长到 2031 年的 6.2751 亿美元，预计 2024-2031 年复合年增长率为 5.1%。

癌症盛行率的快速上升以及专科诊所、医院和门诊手术中心等医疗保健部门不断增长的需求等因素正在加速盐酸羟考酮的采用，从而推动市场占有率的增长。 半合成鸦片类药物盐酸羟考酮和羟吗啡酮甲醚具有镇咳、镇痛作用。 对有效疼痛管理解决方案的日益青睐是市场成长的关键驱动力之一。

老年人口增加导致剧烈疼痛病例增加，支持了市场的扩张。 例如，世界卫生组织（WHO）估计，到2030年，全球六分之一的人口将超过60岁，到2050年，60岁以上的人口将约为21亿。 这种增加似乎增加了对盐酸羟考酮的需求。 盐酸羟考酮用于缓解急性和严重疼痛，因为老年人更容易患有各种与疼痛相关的疾病。 因此，该产品的需求将会增加，全球盐酸羟考酮市场规模将会扩大。

盐酸羟考酮是一种中等效力的鸦片类镇痛药，有助于缓解重度至中度疼痛，是透过一摩尔当量的盐酸与羟考酮反应获得的。 羟考酮与中枢神经系统中的 mu 受体结合，模仿内源性鸦片类药物的作用。 这种化学物质被用作多种药品的活性成分，包括盐酸羟考酮胶囊、Percodan 和 Roxybond。 因此，製药业对这种化学品的需求不断增加，支持了市场的扩张。

癌症盛行率的增加支持了全球盐酸羟考酮市场的成长：

与单独常规治疗相比，在常规治疗中加入盐酸羟考酮可以有效抑制放射性口腔黏膜炎的疼痛。 这种联合疗法还可以帮助患者提高生活品质并显着改善他们的饮食习惯。 已知盐酸羟考酮对脊髓和大脑中的鸦片受体有很强的亲和力，并对骨转移表现出有效的镇痛作用。 许多临床医生使用盐酸羟考酮合併放射治疗来治疗恶性肿瘤骨转移引起的中度至重度疼痛。 这种组合产生了长期和短期镇痛作用。

本报告调查了全球盐酸羟考酮市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素。 、案例研究、竞争格局。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章顾客回馈

  • 市场认知度与产品讯息
  • 品牌知名度与忠诚度
  • 做出购买决定时考虑的因素
  • 购买频率
  • 购买媒介

第五章盐酸羟考酮市场展望

  • 市场规模/预测
  • 依纯度
    • 低于 98%
    • 99% 或以上
  • 依类型
    • 立即发布
    • 受控释放
  • 依形式
    • 固体
    • 液体
  • 依用途
    • 药品製造
    • 研究/学术
    • 其他
  • 依地区
    • 北美
    • 南美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 各公司的市占率

第 6 章盐酸羟考酮市场前景：依地区

  • 北美
  • 南美洲
  • 欧洲
  • 亚太地区
  • 中东/非洲
  • 各公司的市占率

第七章供给面分析

  • 製造能力：依公司划分
  • 产量：依公司划分
  • 入住率：依公司划分
  • 主要工厂地点（最多 25 个地点）

第 8 章市场映射

  • 依纯度
  • 依类型
  • 依形式
  • 依用途
  • 依地区

第九章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • PESTEL 分析
  • 波特五力分析

第 10 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题/障碍）

第十一章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）
  • 专利分析（如果适用）

第十二章价格分析

第 13 章案例研究

第十四章主要公司展望

  • Veranova Bidco, L.P.
  • Euroapi SA
  • Noramco, Inc.
  • Saneca Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Chattem Chemicals Inc.
  • Tiefenbacher API + Ingredients GmbH & Co. KG
  • Sigma-Aldrich (Merck Group)
  • Delphis Pharmaceutical India
  • PluviaEndo

第 15 章策略建议

第十六章查询/免责声明

Product Code: MX11249

Global oxycodone hydrochloride market is projected to witness a CAGR of 5.1% during the forecast period 2024-2031, growing from USD 421.5 million in 2023 to USD 627.51 million in 2031F. The key factors, such as the surging prevalence of cancer and rising requirements by the healthcare sectors, including specialty clinics, hospitals, and ambulatory surgery centers, are accelerating the adoption of oxycodone hydrochloride, which, in turn, is boosting market growth. The hydrochloride salt of oxycodone, a semisynthetic opioid, and methyl ether of oxymorphone have antitussive and analgesic properties. The increasing preference for effective pain management solutions is one of the major significant drivers for market growth.

The market expansion is supported by the increasing old-age population, resulting in higher cases of severe pain. For instance, according to the World Health Organization (WHO) estimates, one in six individuals living across the world will be sixty years or older by the year 2030. By 2050, the population aged sixty and older will be approximately 2.1 billion. This increase will bolster the requirement for oxycodone hydrochloride as it is used for relieving acute and severe pain and the older population is more susceptible to suffering from various pain-related disorders. Thus, propelling the demand for the product and augmenting the global oxycodone hydrochloride market size.

Oxycodone hydrochloride, a moderately potent opioid analgesic aid in relieving severe to moderate pain and is obtained by the reaction of one molar equivalent of hydrochloric acid and oxycodone. The oxycodone binds with the mu-receptors present in the central nervous system and mimics the effects of endogenous opiates. The chemical is used as an active ingredient in various drugs including oxycodone hydrochloride capsules, Percodan, and Roxybond among others. Due to this, the demand for the chemical is rising from the medicine manufacturing sector, thus supporting the expansion of the market.

Increasing Prevalence of Cancer Supports Global Oxycodone Hydrochloride Market Growth

The addition of oxycodone hydrochloride to conventional therapy aids in effectively controlling the pain from radiation-induced oral mucositis as compared to conventional therapy alone. The combination also helps in significantly improving eating habits along with enhancing the quality of life of patients. Oxycodone hydrochloride is known for having a strong affinity for opioid receptors in the spinal cord and brain, allowing it to deliver effective analgesic effects on bone metastases. Many clinicians have combined oxycodone hydrochloride and radiotherapy for treating moderate to severe pain caused due to bone metastases of malignant tumors. This combination has aided them in achieving a combination of long-term and short-term analgesic effects.

For instance, according to the estimates of CONQUER CANCER (The ASCO Foundation), neck and head cancer accounts for approximately 4% of all cancer cases in the United States. It was estimated that in 2023, 66,930 individuals living in the United States will be diagnosed with neck and head cancers. The rising cases of neck and head cancer in various regions across the globe are therefore propelling the requirement for oxycodone hydrochloride. The administration of prolonged-release tablets is derived from this chemical during radiotherapy, effectively reducing the pain that is caused due to radiation-induced oral mucositis for patients suffering from neck and head cancer. Thus, boosting the requirement for oxycodone hydrochloride and supporting the growth of the market.

Rising Number of Surgeries Boost Global Oxycodone Hydrochloride Market Demand

The mechanism of action of oxycodone is similar to that of the other opioids which includes binding to a receptor, inhibiting hyperpolarization of neurons and adenylyl-cyclase, and reducing impulsiveness. Oxycodone hydrochloride is also used as a preemptive analgesia in various gynecological procedures such as gynecological laparoscopic surgery. Oxycodone hydrochloride is an opioid receptor agonist that is mixed-type and has agonistic effects on both μ and κ receptors. It primarily works for the smooth muscles and central nervous system, allowing the effective treatment of visceral pain as compared to other potent opioids. As a result, the adoption of oxycodone hydrochloride is increasing in surgeries.

For instance, according to the estimates of the Lancet Commission on global surgery, approximately 5,000 surgeries per 100,000 population, per year are required. The estimations show that in India, 3,646 surgeries are required per year, per 100,000 population. Of these 13% are ophthalmological surgeries, 20% are gynecological and obstetric surgeries, and 26% are general surgical procedures. This increase is augmenting the requirement for oxycodone hydrochloride as it is used for pain management in moderate and minor surgeries and postoperative pain. Due to such applications and advantages offered by the chemical, the demand for oxycodone hydrochloride is increasing, supporting the expansion of the market.

North America Holds a Significant Share of the Market

The increasing prevalence of head and neck cancer in the region and the surging requirement for different surgical procedures are major factors supporting the growth of the North America oxycodone hydrochloride market. The augmenting consumption of prescription drugs in the region for effectively managing pain caused by various conditions such as cancer and neuralgia is another major factor propelling the requirement for oxycodone hydrochloride in North America. Additionally, the Food and Drug Administration (FDA) has also approved various prescription drugs that use oxycodone hydrochloride for pain management. The growing requirement for surgical procedures is also boosting the requirement for oxycodone hydrochloride as it is deployed for treating postoperative pain. For instance, according to the estimates of Johns Hopkins Medicine, the most common surgical operations conducted in the United States include appendectomy, breast biopsy, coronary artery bypass, and cholecystectomy. Thus, increasing the demand for oxycodone hydrochloride to ensure the production of drugs that aid patients in effective management of postoperative pain.

Controlled Release Accounts for Significant Global Oxycodone Hydrochloride Market Share

The segment's growth can be attributed to the increasing utilization of controlled-release tablets for relieving severe to moderate persistent pain in situations where other forms of pain treatment solutions have been rendered ineffective. These products are also deployed in situations where continuous analgesics are required for an extended duration of time. The oxycodone hydrochloride-controlled release tablets are opioid analgesics that are orally administered and available in 20 mg and 10 mg strengths. The tablets contain various inactive ingredients including titanium dioxide, ammonio methacrylate copolymer, polyethylene glycol 400, sorbic acid, triacetin, sodium hydroxide, povidone, magnesium stearate, lactose, Hypromellose, talc, and stearyl alcohol. For instance, tablets with 20 mg strength also contain red iron oxide and polysorbate 80 and the tablet with 10 mg strength also contains hydroxypropyl cellulose. These controlled-release tablets are designed to ensure the controlled delivery of oxycodone over twelve hours. The release of oxycodone from these tablets is independent of pH and the oxycodone released from the tablets is absorbed at a bioavailability of 60%-87%. Thus, utilization of controlled-release tablets is boosting the segment's expansion and supporting the global oxycodone hydrochloride market growth.

Increased Product Requirement for Medicine Manufacturing Supports Market Expansion

The rising incidences of cancer and the increasing requirement for surgical procedures for the treatment and management of various health conditions is boosting the demand for oxycodone hydrochloride. This augmentation can be attributed to the effective pain management offered by the chemical in both minor surgical procedures and postoperative pain. The growing emphasis on patient care in various healthcare facilities is another major factor bolstering the requirement for oxycodone hydrochloride-based medication for effective management of severe and acute pain, propelling the expansion of the segment and boosting the global oxycodone hydrochloride market growth. The surge in the aging populace is another major factor supporting the growth of the segment as the older population is more susceptible to various pain-causing disorders and requires various surgical procedures to ensure proper management and treatment of various health conditions. For instance, according to a research article published by researchers from the Department of Urology and Department of Population Health Sciences, Geisinger, Danville, PA, approximately 4 million surgical procedures are performed every year in individuals aged 65 or older. Thus, bolstering the requirement for oxycodone hydrochloride for manufacturing medicine for the management of pain post-surgical procedures.

Future Market Scenario (2024-2031F)

According to the global oxycodone hydrochloride market analysis, various interventional studies are underway to evaluate the safety, efficacy, tolerability, and pharmacokinetic effects of oxycodone. For instance, Zuyderland Medisch Centrum is currently conducting a study to identify the impact of intercostal nerve cryoablation on the length of the postoperative hospital stay in comparison to the standard pain management of pectus excavatum patients. The randomized, single-center, unblinded, and prospective clinical trial is estimated to reach completion by September 2025. The increase in the number of such trials is propelling the requirement for oxycodone hydrochloride and aiding in evaluating the safety and efficacy of the chemical, thus increasing product applications and boosting the growth of the market.

Key Players Landscape and Outlook

The expansion of the market is supported by the rising investments by various companies in research and development activities. Furthermore, they are collaborating with other companies and organizations to support their R&D activities, which is expected to provide lucrative growth opportunities for the market. Various studies are conducted globally to evaluate the possible health benefits resulting from oxycodone hydrochloride.

For instance, OpalGenix, Inc., a developer of genetic tests for pain management and precision opioids is sponsoring an observational study to evaluate the effects of interactions and multiple genes on methadone and oxycodone's pharmacokinetics. The study is expected to conclude in September 2024. Such studies aid in determining the working and efficacy of the pain management solutions that deploy oxycodone hydrochloride, thus boosting the product demand and augmenting the market expansion.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Market Awareness and Product Information
  • 4.2.Brand Awareness and Loyalty
  • 4.3.Factors Considered in Purchase Decision
    • 4.3.1.Brand Name
    • 4.3.2.Quality
    • 4.3.3.Quantity
    • 4.3.4.Price
    • 4.3.5.Product Specification
    • 4.3.6.Form Specification
    • 4.3.7.Shelf Life
    • 4.3.8.Availability of Product
  • 4.4.Frequency of Purchase
  • 4.5.Medium of Purchase

5.Global Oxycodone Hydrochloride Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Purity
    • 5.2.1.Less than 98%
    • 5.2.2.98% to 99%
    • 5.2.3.More than 99%
  • 5.3.By Type
    • 5.3.1.Immediate Release
    • 5.3.2.Controlled Release
  • 5.4.By Form
    • 5.4.1.Solid
    • 5.4.2.Liquid
  • 5.5.By Application
    • 5.5.1.Medicine Manufacturing
    • 5.5.2.Research and Academics
    • 5.5.3.Others
  • 5.6.By Region
    • 5.6.1.North America
    • 5.6.2.South America
    • 5.6.3.Europe
    • 5.6.4.Asia-Pacific
    • 5.6.5.Middle East & Africa
  • 5.7.By Company Market Share (%), 2023

6.Global Oxycodone Hydrochloride Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Purity
      • 6.1.2.1.Less than 98%
      • 6.1.2.2.98% to 99%
      • 6.1.2.3.More than 99%
    • 6.1.3.By Type
      • 6.1.3.1.Immediate Release
      • 6.1.3.2.Controlled Release
    • 6.1.4.By Form
      • 6.1.4.1.Solid
      • 6.1.4.2.Liquid
    • 6.1.5.By Application
      • 6.1.5.1.Medicine Manufacturing
      • 6.1.5.2.Research and Academics
      • 6.1.5.3.Others
    • 6.1.6.United States*
      • 6.1.6.1.Market Size & Forecast
      • 6.1.6.1.1.By Value
      • 6.1.6.1.2.By Volume
      • 6.1.6.2.By Purity
      • 6.1.6.2.1.Less than 98%
      • 6.1.6.2.2.98% to 99%
      • 6.1.6.2.3.More than 99%
      • 6.1.6.3.By Type
      • 6.1.6.3.1.Immediate Release
      • 6.1.6.3.2.Controlled Release
      • 6.1.6.4.By Form
      • 6.1.6.4.1.Solid
      • 6.1.6.4.2.Liquid
      • 6.1.6.5.By Application
      • 6.1.6.5.1.Medicine Manufacturing
      • 6.1.6.5.2.Research and Academics
      • 6.1.6.5.3.Others
    • 6.1.7.Canada
    • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Supply Side Analysis

  • 7.1.Capacity, By Company
  • 7.2.Production, By Company
  • 7.3.Operating Efficiency, By Company
  • 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

  • 8.1.By Purity
  • 8.2.By Type
  • 8.3.By Form
  • 8.4.By Application
  • 8.5.By Region

9.Macro Environment and Industry Structure

  • 9.1.Supply Demand Analysis
  • 9.2.Import Export Analysis
  • 9.3.Value Chain Analysis
  • 9.4.PESTEL Analysis
    • 9.4.1.Political Factors
    • 9.4.2.Economic System
    • 9.4.3.Social Implications
    • 9.4.4.Technological Advancements
    • 9.4.5.Environmental Impacts
    • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 9.5.Porter's Five Forces Analysis
    • 9.5.1.Supplier Power
    • 9.5.2.Buyer Power
    • 9.5.3.Substitution Threat
    • 9.5.4.Threat from New Entrant
    • 9.5.5.Competitive Rivalry

10.Market Dynamics

  • 10.1.Growth Drivers
  • 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

  • 11.1.Competition Matrix of Top Five Market Leaders
  • 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4.SWOT Analysis (For Five Market Players)
  • 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

  • 14.1.Veranova Bidco, L.P.
    • 14.1.1.Company Details
    • 14.1.2.Key Management Personnel
    • 14.1.3.Products & Services
    • 14.1.4.Financials (As reported)
    • 14.1.5.Key Market Focus & Geographical Presence
    • 14.1.6.Recent Developments
  • 14.2.Euroapi SA
  • 14.3.Noramco, Inc.
  • 14.4.Saneca Pharmaceuticals
  • 14.5.Sun Pharmaceutical Industries Ltd.
  • 14.6.Chattem Chemicals Inc.
  • 14.7.Tiefenbacher API + Ingredients GmbH & Co. KG
  • 14.8.Sigma-Aldrich (Merck Group)
  • 14.9.Delphis Pharmaceutical India
  • 14.10.PluviaEndo

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 3.Global Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 4.Global Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 5.Global Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 6.Global Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 7.Global Oxycodone Hydrochloride Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 9.North America Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 10.North America Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 11.North America Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 12.North America Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 13.North America Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 14.North America Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 16.United States Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 17.United States Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 18.United States Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 19.United States Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 20.United States Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 21.Canada Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 22.Canada Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 23.Canada Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 24.Canada Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 25.Canada Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 26.Canada Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 27.Mexico Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 28.Mexico Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 29.Mexico Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 30.Mexico Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 31.Mexico Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 32.Mexico Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 33.Europe Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 34.Europe Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 35.Europe Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 36.Europe Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 37.Europe Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 38.Europe Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 39.Europe Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 41.Germany Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 42.Germany Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 43.Germany Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 44.Germany Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 45.Germany Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 46.France Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 47.France Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 48.France Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 49.France Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 50.France Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 51.France Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 52.Italy Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Italy Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 54.Italy Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 55.Italy Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 56.Italy Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 57.Italy Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 58.United Kingdom Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 59.United Kingdom Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 60.United Kingdom Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 61.United Kingdom Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 62.United Kingdom Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 63.United Kingdom Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 64.Russia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 65.Russia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 66.Russia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 67.Russia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 68.Russia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 69.Russia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 70.Netherlands Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 71.Netherlands Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 72.Netherlands Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 73.Netherlands Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 74.Netherlands Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 75.Netherlands Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 76.Spain Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 77.Spain Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 78.Spain Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 79.Spain Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 80.Spain Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 81.Spain Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 82.Turkey Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 83.Turkey Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 84.Turkey Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 85.Turkey Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 86.Turkey Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 87.Turkey Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 88.Poland Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 89.Poland Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 90.Poland Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 91.Poland Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 92.Poland Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 93.Poland Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 94.South America Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 95.South America Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 96.South America Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 97.South America Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 98.South America Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 99.South America Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 100.South America Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 102.Brazil Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 103.Brazil Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 104.Brazil Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 105.Brazil Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 106.Brazil Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 107.Argentina Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 108.Argentina Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 109.Argentina Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 110.Argentina Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 111.Argentina Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 112.Argentina Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 113.Asia-Pacific Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 114.Asia-Pacific Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 115.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 116.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 117.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 118.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 119.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
  • Figure 120.India Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 121.India Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 122.India Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 123.India Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 124.India Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 125.India Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 126.China Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 127.China Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 128.China Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 129.China Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 130.China Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 131.China Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 132.Japan Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 133.Japan Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 134.Japan Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 135.Japan Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 136.Japan Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 137.Japan Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 138.Australia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 139.Australia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 140.Australia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 141.Australia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 142.Australia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 143.Australia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 144.Vietnam Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 145.Vietnam Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 146.Vietnam Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 147.Vietnam Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 148.Vietnam Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 149.Vietnam Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 150.South Korea Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 151.South Korea Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 152.South Korea Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 153.South Korea Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 154.South Korea Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 155.South Korea Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 156.Indonesia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 157.Indonesia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 158.Indonesia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 159.Indonesia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 160.Indonesia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 161.Indonesia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 162.Philippines Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 163.Philippines Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 164.Philippines Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 165.Philippines Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 166.Philippines Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 167.Philippines Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 168.Middle East & Africa Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 169.Middle East & Africa Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 170.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 171.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 172.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 173.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 174.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 176.Saudi Arabia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 177.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 178.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 179.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 180.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 181.UAE Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 182.UAE Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 183.UAE Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 184.UAE Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 185.UAE Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 186.UAE Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 187.South Africa Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
  • Figure 188.South Africa Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
  • Figure 189.South Africa Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
  • Figure 190.South Africa Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
  • Figure 191.South Africa Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
  • Figure 192.South Africa Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
  • Figure 193.By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194.By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195.By Form Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023